Showing 1 - 6 results of 6 for search 'Suguru Fukuhara', query time: 0.03s Refine Results
  1. 1
    The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype

    The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype by Yu Aruga, Chiaki Ikeda, Hiromichi Matsushita, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Koji Izutsu, Hirotaka Matsui

    Published 2024-06-01
    Get full text
    Article
  2. 2
    The role of surveillance computed tomography in patients with follicular lymphoma

    The role of surveillance computed tomography in patients with follicular lymphoma by Shunsuke Hatta, Suguru Fukuhara, Takahiro Fujino, Yo Saito, Yuta Ito, Shinichi Makita, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Masahiko Kusumoto, Koji Izutsu

    Published 2022-05-01
    Get full text
    Article
  3. 3
    The outcome of watchful waiting in patients with previously treated follicular lymphoma

    The outcome of watchful waiting in patients with previously treated follicular lymphoma by Takahiro Fujino, Dai Maruyama, Akiko‐Miyagi Maeshima, Yo Saito, Hanae Ida, Rika Hosoba, Sayako Yuda, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Junya Kuroda, Koji Izutsu

    Published 2022-05-01
    Get full text
    Article
  4. 4
    Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin

    Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refracto... by Ritsuko Nakai, Suguru Fukuhara, Akiko Miyagi Maeshima, Sung‐Won Kim, Yuta Ito, Shunsuke Hatta, Tomotaka Suzuki, Sayako Yuda, Shinichi Makita, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Koji Izutsu

    Published 2019-12-01
    Get full text
    Article
  5. 5
    Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmunotherapy

    Clinicopathological analysis of primary refractory diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone chemoimmun... by Tomotaka Suzuki, Dai Maruyama, Akiko Miyagi‐Maeshima, Junko Nomoto, Kinuko Tajima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Hirokazu Taniguchi, Koji Izutsu, Yukio Kobayashi, Kensei Tobinai

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors

    Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late... by Tomotaka Suzuki, Suguru Fukuhara, Junko Nomoto, Satoshi Yamashita, Akiko (Miyagi) Maeshima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Hirokazu Taniguchi, Toshikazu Ushijima, Koji Izutsu, Kensei Tobinai, Yukio Kobayashi

    Published 2020-03-01
    Get full text
    Article

Search Tools: